ProKidney (MEX:PROK) Marketable Securities : MXN4,059.59 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. ProKidney's Marketable Securities for the quarter that ended in Mar. 2024 was MXN4,059.59 Mil.

ProKidney's annual Marketable Securities stayed the same from Dec. 2021 (MXN0.00 Mil) to Dec. 2022 (MXN0.00 Mil) but then increased from Dec. 2022 (MXN0.00 Mil) to Dec. 2023 (MXN5,131.33 Mil).

ProKidney Marketable Securities Historical Data

The historical data trend for ProKidney's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Marketable Securities Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Marketable Securities

5,131.33

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial									3,461.63	3,472.93	3,569.92	5,131.33	4,059.59

ProKidney Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

ProKidney (MEX:PROK) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

ProKidney Marketable Securities Related Terms

Thank you for viewing the detailed overview of ProKidney's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney (MEX:PROK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.